CECILIA PORCHER: Open Payments
NPI 1336572650 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,709 in 90 payments from 17 companies in 2025. Trend: 2023 $1,456 · 2024 $2,281 · 2025 $1,709
Food & beverage: $1,709
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 13 | $268 |
| Amgen Inc. | 19 | $263 |
| Novartis Pharmaceuticals Corporation | 8 | $209 |
| Alnylam Pharmaceuticals Inc. | 11 | $178 |
| Novo Nordisk Inc | 7 | $166 |
| Merck Sharp & Dohme LLC | 8 | $148 |
| AstraZeneca Pharmaceuticals LP | 6 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $101 |
| E.R. Squibb & Sons, L.L.C. | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
Products named: Attruby, Repatha, ONPATTRO, LEQVIO, Wegovy, VERQUVO, JARDIANCE, FARXIGA.
Industry payments across SC — which companies pay providers there.
